$18.77
1.52% yesterday
Nasdaq, Jul 11, 10:00 pm CET
ISIN
US45781M1018
Symbol
INVA

Innoviva Target price 2025 - Analyst rating & recommendation

Innoviva Classifications & Recommendation:

Buy
86%
Hold
14%

Innoviva Price Target

Target Price $56.10
Price $18.77
Potential
Number of Estimates 3
3 Analysts have issued a price target Innoviva 2026 . The average Innoviva target price is $56.10. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 6 Analysts recommend Innoviva to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Innoviva stock has an average upside potential 2026 of . Most analysts recommend the Innoviva stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 358.71 372.17
15.54% 3.75%
EBITDA Margin 53.74% 43.00%
22.98% 19.98%
Net Margin 6.52% 11.53%
88.74% 76.82%

3 Analysts have issued a sales forecast Innoviva 2025 . The average Innoviva sales estimate is

$372m
Unlock
. This is
0.63% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$383m 3.59%
Unlock
, the lowest is
$358m 3.32%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $359m 15.54%
2025
$372m 3.75%
Unlock
2026
$419m 12.62%
Unlock
2027
$488m 16.35%
Unlock
2028
$587m 20.31%
Unlock
2029
$709m 20.83%
Unlock
2030
$902m 27.28%
Unlock
2031
$1.1b 16.37%
Unlock
2032
$1.2b 12.19%
Unlock

3 Analysts have issued an Innoviva EBITDA forecast 2025. The average Innoviva EBITDA estimate is

$160m
Unlock
. This is
23.22% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$165m 20.96%
Unlock
, the lowest is
$154m 26.23%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $193m 42.09%
2025
$160m 16.98%
Unlock
2026
$147m 8.32%
Unlock
2027
$132m 9.79%
Unlock

EBITDA Margin

2024 53.74% 22.98%
2025
43.00% 19.98%
Unlock
2026
35.00% 18.60%
Unlock
2027
27.14% 22.46%
Unlock

3 Innoviva Analysts have issued a net profit forecast 2025. The average Innoviva net profit estimate is

$42.9m
Unlock
. This is
171.84% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$44.2m 173.95%
Unlock
, the lowest is
$41.2m 169.01%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $23.4m 86.99%
2025
$42.9m 83.41%
Unlock
2026
$172m 299.98%
Unlock
2027
$225m 31.34%
Unlock
2028
$302m 33.81%
Unlock
2029
$375m 24.42%
Unlock
2030
$499m 32.94%
Unlock
2031
$586m 17.46%
Unlock
2032
$661m 12.79%
Unlock

Net Margin

2024 6.52% 88.74%
2025
11.53% 76.82%
Unlock
2026
40.94% 255.07%
Unlock
2027
46.21% 12.87%
Unlock
2028
51.40% 11.23%
Unlock
2029
52.93% 2.98%
Unlock
2030
55.28% 4.44%
Unlock
2031
55.79% 0.92%
Unlock
2032
56.09% 0.54%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.31 0.68
84.95% 119.35%
P/E 27.47
EV/Sales 3.17

3 Analysts have issued a Innoviva forecast for earnings per share. The average Innoviva EPS is

$0.68
Unlock
. This is
171.58% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.70 173.68%
Unlock
, the lowest is
$0.66 169.47%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.31 84.95%
2025
$0.68 119.35%
Unlock
2026
$2.73 301.47%
Unlock
2027
$3.59 31.50%
Unlock
2028
$4.80 33.70%
Unlock
2029
$5.98 24.58%
Unlock
2030
$7.95 32.94%
Unlock
2031
$9.33 17.36%
Unlock
2032
$10.53 12.86%
Unlock

P/E ratio

Current -19.76 380.19%
2025
27.47 239.03%
Unlock
2026
6.87 74.99%
Unlock
2027
5.23 23.87%
Unlock
2028
3.91 25.24%
Unlock
2029
3.14 19.69%
Unlock
2030
2.36 24.84%
Unlock
2031
2.01 14.83%
Unlock
2032
1.78 11.44%
Unlock

Based on analysts' sales estimates for 2025, the Innoviva stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.19 15.83%
2025
3.17 0.58%
Unlock
2026
2.82 11.21%
Unlock
2027
2.42 14.05%
Unlock
2028
2.01 16.88%
Unlock
2029
1.67 17.24%
Unlock
2030
1.31 21.44%
Unlock
2031
1.12 14.07%
Unlock
2032
1.00 10.86%
Unlock

P/S ratio

Current 3.19 3.08%
2025
3.17 0.62%
Unlock
2026
2.81 11.21%
Unlock
2027
2.42 14.05%
Unlock
2028
2.01 16.88%
Unlock
2029
1.66 17.24%
Unlock
2030
1.31 21.43%
Unlock
2031
1.12 14.07%
Unlock
2032
1.00 10.87%
Unlock

Current Innoviva Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Cantor Fitzgerald
Locked
Locked
Locked Jul 11 2025
Scotiabank
Locked
Locked
Locked Mar 07 2025
Analyst Rating Date
Locked
Cantor Fitzgerald:
Locked
Locked
Jul 11 2025
Locked
Scotiabank:
Locked
Locked
Mar 07 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today